Akari Yamazaki May 2026

In the field of neurology, Akari Yamazaki is a prominent research researcher at the Mayo Clinic Department of Neuroscience. Her work primarily revolves around understanding how the brain's complex vascular systems intersect with neurodegenerative diseases like Alzheimer's disease (AD). Pioneering Brain Vascular Profiling

A significant portion of her co-authored work focuses on the apolipoprotein E (APOE) gene—specifically the ε4 allele, which is the strongest genetic risk factor for Alzheimer's disease. akari yamazaki

: Her research published in journals like Arteriosclerosis, Thrombosis, and Vascular Biology has demonstrated that ApoE in Brain Pericytes regulates endothelial cell phenotype. This showed that ApoE4 impairs the basement membrane formation of capillaries, contributing to cognitive decline. In the field of neurology, Akari Yamazaki is

is a name associated with two distinct, highly specialized researchers in contemporary Japanese science: one breaking ground in neurovascular biology and Alzheimer's disease pathology at the Mayo Clinic, and the other innovating in organic chemistry and functional materials at Shinshu University. Depending on the specific field of interest, 🔬 Focus 1: Akari Yamazaki in Neuroscience : Her research published in journals like Arteriosclerosis,

One of Yamazaki’s most notable technical contributions to the scientific community is her work on profiling the transcriptomics of the blood-brain barrier.

In the physical sciences, Akari Yamazaki is a talented chemist at Shinshu University in Japan, working heavily within the Graduate School of Science and Technology. Her work leans toward the synthesis, reactivity, and properties of non-benzenoid aromatic compounds. Exploring Azulene Derivatives